Elizabeth Serra
Education
M.Sc., public health, McGill University; B.S., biology (honours), Bishop’s University
Summary of Experience
Ms. Serra specializes in epidemiology and health economics and outcomes research. She has extensive experience in retrospective database and claims database analyses; patient, physician, and caregiver survey studies; and the assessment of treatment patterns, burden of illness, and real-world safety and effectiveness of treatments. Ms. Serra has conducted research in multiple therapeutic areas, including ophthalmology, dermatology, gastroenterology, and psychiatry. Her research has been presented at conferences such as the International Society for Pharmacoeconomics and Outcomes Research, the Academy of Managed Care Pharmacy, and the American Academy of Dermatology, and published in peer-reviewed journals such as the Journal of Medical Economics, BMC Psychiatry, and the Journal of Managed Care & Specialty Pharmacy.
-
Patient and Care Partner Burden in CKD Patients With and Without Anemia: A US-Based Survey
Kidney Medicine, 2022
2022Michalopoulos SN, Gauthier-Loiselle M, Aigbogun MS, Serra E, Bungay R, Clynes D, Cloutier M, Kahle E, Guérin A, Farag YMK, Wish JB
-
Identifying Individuals with Undiagnosed Post-Traumatic Stress Disorder in a Large United States Civilian Population – A Machine Learning Approach
BMC Psychiatry, 2022
2022Gagnon-Sanschagrin P, Schein J, Urganis A, Serra E, Liang Y, Musingarimi P, Cloutier M, Guérin A, Davis L
-
Impact of agitation in long-term care residents with dementia in the United States
International Journal of Geriatric Psychiatry, 2021
2021Fillit H, Aigbogun MS, Gagnon-Sanschagrin P, Cloutier M, Davidson M, Serra E, Guérin A, Baker RA, Houle CR, Grossberg G
-
Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer's perspective
BMJ Open Opthalmology, 2021
2021Hariprasad SM, Joseph G, Gagnon-Sanschagrin P, Serra E, Bhattacharyya S, Bédard J, Guérin A, Albini TA
-
Costs associated with the administration of erythropoiesis-stimulating agents for the treatment of anemia in patients with non-dialysis-dependent chronic kidney disease: a US societal perspective
Journal of Managed Care & Specialty Pharmacy, 2021
2021Gauthier-Loiselle M, Michalopoulos SN, Cloutier M, Serra E, Bungay R, Szabo E, Guérin A
-
Vaso-occlusive crises and costs of sickle cell disease in patients with commercial, Medicaid, and Medicare insurance - the perspective of private and public payers
Journal of Medical Economics, 2020
2020Shah NR, Bhor M, Latremouille-Viau D, Sharma VK, Puckrein GA, Gagnon-Sanschagrin P, Khare A, Singh MK, Serra E, Davidson M, Xu L, Guerin A